サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1757939

依存症治療の世界市場

Addiction Therapeutics

出版日
ページ情報
英文 281 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
依存症治療の世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 281 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

依存症治療の世界市場は2030年までに360億米ドルに達する見込み

2024年に252億米ドルと推定される依存症治療の世界市場は、2024年から2030年にかけてCAGR 6.2%で成長し、2030年には360億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるアルコール依存症治療は、CAGR 4.9％を記録し、分析期間終了時には182億米ドルに達すると予測されます。タバコ依存症治療セグメントの成長率は、分析期間中CAGR 7.8％と推定されます。

米国市場は69億米ドル、中国はCAGR 9.5％で成長予測

米国の依存症治療市場は、2024年に69億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに73億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.1％と6.0％と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の依存症治療市場- 主要動向と促進要因のまとめ

依存症治療が公衆衛生、行動医学、医薬品イノベーションにおいて戦略的重要性を増している理由とは？

依存症治療は、オピオイド依存症、アルコール依存症、ニコチン依存症、覚せい剤依存症などの薬物使用障害（SUDs）の負担が増加し続ける中、世界の健康上の急務となっています。依存症が道徳的な失敗ではなく、慢性的な神経行動学的状態であると広く認識されるようになった現在、薬理学的介入は包括的な治療戦略の中核をなすものとして受け入れられつつあります。渇望、離脱症状、再発予防を管理することを目的とした治療薬は、リハビリテーション、精神科、プライマリ・ケアのあらゆる場面で臨床的な支持を集めています。

北米におけるオピオイド危機、欧州におけるアルコール依存症、アジア太平洋における覚せい剤乱用の増加により、各国政府は国のヘルスケア課題として依存症治療を優先するようになりました。精神衛生上の課題の増加、経済的不安、パンデミックによる孤立など、より広範な社会的要因が、利用しやすくエビデンスに基づく治療ソリューションの緊急性をさらに高めています。需要が高まるにつれて、依存症治療は公的保険制度、従業員支援プログラム、裁判所が強制する治療イニシアティブに組み込まれつつあります。

依存症治療における医薬品の技術革新も勢いを増しており、神経受容体（オピオイド、ドーパミン、GABAなど）を調節し、報酬経路を遮断し、うつ病や不安症を含む二重診断を管理する薬剤の開発に力を入れています。これらの治療法は、物質依存を軽減するだけでなく、神経学的バランスや行動機能を回復させるよう設計されており、回復志向のヘルスケアモデルにおける中心的役割を強調しています。

新しいメカニズム、デジタル統合、政策改革は、依存症治療をどのように進化させているのでしょうか？

依存症治療のパイプラインは、神経薬理学の進歩により拡大し、より的を絞った忍容性の高い介入を提供しています。長時間作用型の注射剤、デポ製剤、埋め込み型デバイスは、アドヒアランスの課題に対処し、誤用の可能性を減らしています。報酬回路の部分作動薬、拮抗薬、モジュレーターは、アルコールやオピオイドからギャンブルやゲームのような新たな行動依存症まで、幅広い依存症に対して臨床開発中です。

モバイルヘルスアプリ、バーチャル行動サポート、AIによるアドヒアランスモニタリングなどのデジタルツールの統合は、薬物療法の有効性を高めています。これらのツールは、服薬リマインダー、渇望の追跡、バーチャルな治療サポートを容易にし、薬理学的治療と心理社会的治療を融合させたハイブリッドなケアモデルを提供します。デジタル・セラピューティクス（DTx）は、特にテレヘルスの導入が進んでいる市場や、バリューベースのケアモデルに対する支払者のサポートがある市場において、処方薬との組み合わせが増加しています。

政策改革により、中毒治療薬への長年のアクセス障壁が取り除かれつつあります。ナースプラクティショナーへの処方権の拡大、特定の薬剤に対するカウンセリングの義務化の縮小、併用療法に対する償還の合理化などが、取り込みを促進しています。さらに、規制当局は、中毒の危機の緊急性を認識し、画期的な治療薬の承認を迅速化するため、ファスト・トラック制度や優先審査制度を導入しています。これらの改革は、早期介入を促進し、スティグマを減らし、懲罰的アプローチよりも害の軽減を優先させることで、治療の状況を再構築しています。

依存症治療の成長を牽引している患者集団、治療手段、地域市場は？

主要な患者集団には、オピオイド使用障害（OUD）の患者が含まれ、特に米国とカナダでは、現在の治療薬の主要な焦点となっています。アルコール使用障害（AUD）は、特に欧州とラテンアメリカの一部において、世界的に治療需要のかなりの割合を占めています。処方薬と市販薬の両方を含む禁煙治療薬も、すべての地域で大量かつ幅広いアクセスを有する分野です。

治療方法は、解毒支援や維持療法から再発予防や二重診断管理まで多岐にわたる。一般的な薬理学的薬剤には、メタドン、ブプレノルフィン、ナルトレキソン、アカンプロサート、ジスルフィラム、バレニクリンなどがあり、それぞれが特定の物質依存や患者プロファイルに沿ったものです。新たな治療法としては、カンナビノイドに基づく治療法、サイケデリック補助介入、新規神経学的標的を持つ抗渇望薬などがあります。

北米が依存症治療市場をリードしているのは、旺盛なヘルスケア資金、進行中の公衆衛生上の危機、先進的な臨床インフラによるものです。欧州は、国民皆保険制度や先進的な薬物政策環境に支えられており、僅差で続いています。アジア太平洋地域では、特にアルコールや覚せい剤の乱用に悩む都市部で導入が進んでいます。しかし、スティグマ（烙印）、専門医療機関へのアクセス制限、保険適用範囲の狭さなどが、新興市場では依然として障壁となっています。

依存症治療は、将来の医療システム、社会のレジリエンス、精神神経医療イノベーションの形成において、どのような戦略的役割を果たすのでしょうか？

依存症治療は、統合された、アウトカム重視の、社会的対応のあるケアモデルへとヘルスケアシステムを移行させる上で、戦略的な役割を果たす用意があります。依存症、メンタルヘルス、社会的決定要因の関連性がより明らかになるにつれ、薬理学的介入は、住居、雇用、ピアサポート、司法改革にまたがる、より広範な回復のエコシステムに組み込まれつつあります。

製薬会社やバイオテクノロジー企業は、この勢いを利用して、心的外傷後ストレス障害、オピオイドを使用しない慢性疼痛、神経再生といった隣接する治療領域を探求しており、従来の依存症治療を超えたイノベーションの地平を広げています。公衆衛生機関、保険会社、テクノロジーを駆使した治療プロバイダーが関与する共同資金提供モデルは、データ豊富で患者中心の治療個別化アプローチを可能にしています。

社会の態度が犯罪化から思いやりや科学主導のケアへと変化する中、依存症治療は、世界産業アナリストが薬物関連障害や行動健康障害をどのように治療し、認識し、最終的に予防するかという世界の変革の礎石となり得るだろうか。

セグメント

タイプ（アルコール依存症治療、タバコ依存症治療、ドラッグ依存症治療）;流通チャネル（病院薬局、小売薬局、その他の流通チャネル）

調査対象企業の例（合計 44注目）

  • Alkermes plc
  • Alkaloid AD Skopje
  • Biovail Corporation
  • Camurus AB
  • Durect Corporation
  • Indivior PLC
  • Jazz Pharmaceuticals plc
  • Lundbeck A/S
  • Mallinckrodt Pharmaceuticals
  • MediciNova, Inc.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Retrophin, Inc.
  • Shionogi & Co., Ltd.
  • Sunovion Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Titan Pharmaceuticals, Inc.
  • Zogenix, Inc.

AI統合

私たちは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36068

Global Addiction Therapeutics Market to Reach US$36.0 Billion by 2030

The global market for Addiction Therapeutics estimated at US$25.2 Billion in the year 2024, is expected to reach US$36.0 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Alcohol Addiction Therapeutics, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$18.2 Billion by the end of the analysis period. Growth in the Tobacco Addiction Therapeutics segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 9.5% CAGR

The Addiction Therapeutics market in the U.S. is estimated at US$6.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2030 trailing a CAGR of 9.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Addiction Therapeutics Market - Key Trends & Drivers Summarized

Why Are Addiction Therapeutics Gaining Strategic Significance Across Public Health, Behavioral Medicine, and Pharmaceutical Innovation?

Addiction therapeutics are becoming a global health imperative as the burden of substance use disorders (SUDs)-including opioid, alcohol, nicotine, and stimulant dependencies-continues to rise. With addiction now widely recognized as a chronic neurobehavioral condition rather than a moral failing, there is growing acceptance of pharmacological intervention as a core component of comprehensive treatment strategies. Therapeutics aimed at managing cravings, withdrawal symptoms, and relapse prevention are gaining clinical traction across rehabilitation, psychiatric, and primary care settings.

The opioid crisis in North America, alcohol dependence in Europe, and increasing stimulant abuse in Asia-Pacific have prompted governments to prioritize addiction treatment under national healthcare agendas. Broader social drivers-such as rising mental health challenges, economic insecurity, and pandemic-induced isolation-are further amplifying the urgency of accessible, evidence-based treatment solutions. As demand escalates, addiction therapeutics are being integrated into public insurance schemes, employee assistance programs, and court-mandated treatment initiatives.

Pharmaceutical innovation in addiction therapy is also gaining momentum, with efforts focused on developing drugs that modulate neuroreceptors (e.g., opioid, dopamine, GABA), block reward pathways, and manage dual diagnoses involving depression or anxiety. These treatments are being designed not only to reduce substance dependence but also to restore neurological balance and behavioral function, highlighting their centrality in recovery-oriented healthcare models.

How Are Novel Mechanisms, Digital Integration, and Policy Reforms Driving the Evolution of Addiction Therapeutics?

The addiction therapeutics pipeline is expanding through advances in neuropharmacology, offering more targeted and tolerable interventions. Long-acting injectables, depot formulations, and implantable devices are addressing adherence challenges and reducing misuse potential. Partial agonists, antagonists, and modulators of reward circuitry are under clinical development for a wide spectrum of addictions-ranging from alcohol and opioids to emerging behavioral addictions like gambling and gaming.

Integration of digital tools-including mobile health apps, virtual behavioral support, and AI-driven adherence monitoring-is enhancing the effectiveness of pharmacotherapy. These tools facilitate medication reminders, craving tracking, and virtual therapy support, offering a hybrid care model that blends pharmacological and psychosocial treatment. Digital therapeutics (DTx) are increasingly paired with prescription drugs, particularly in markets with strong telehealth adoption and payer support for value-based care models.

Policy reforms are removing longstanding access barriers to addiction medications. Expansion of prescribing rights to nurse practitioners, reduction of mandatory counseling requirements for certain medications, and streamlining of reimbursement for combination therapies are catalyzing uptake. Additionally, regulatory bodies are accelerating approvals for breakthrough therapies under fast-track or priority review programs, recognizing the urgency of the addiction crisis. These reforms are reshaping the treatment landscape by promoting early intervention, reducing stigma, and prioritizing harm reduction over punitive approaches.

Which Patient Populations, Treatment Modalities, and Regional Markets Are Driving the Growth of Addiction Therapeutics?

Key patient groups include individuals with opioid use disorder (OUD), which remains the primary focus of current therapeutics, particularly in the U.S. and Canada. Alcohol use disorder (AUD) accounts for a substantial share of treatment demand globally, especially in Europe and parts of Latin America. Tobacco cessation products, including both prescription medications and over-the-counter options, also represent a high-volume, broad-access segment across all geographies.

Treatment modalities range from detoxification support and maintenance therapy to relapse prevention and dual-diagnosis management. Common pharmacological agents include methadone, buprenorphine, naltrexone, acamprosate, disulfiram, and varenicline, each aligned with specific substance dependencies and patient profiles. Emerging modalities include cannabinoid-based therapies, psychedelic-assisted interventions, and anti-craving agents with novel neurological targets.

North America leads the addiction therapeutics market due to robust healthcare funding, ongoing public health crises, and advanced clinical infrastructure. Europe follows closely, supported by universal healthcare systems and progressive drug policy environments. Asia-Pacific is showing increasing adoption, particularly in urban centers grappling with alcohol and stimulant abuse. However, stigma, limited access to specialized providers, and variable insurance coverage remain barriers in emerging markets.

What Strategic Role Will Addiction Therapeutics Play in Shaping Future Health Systems, Societal Resilience, and Neuropsychiatric Care Innovation?

Addiction therapeutics are poised to play a strategic role in transitioning healthcare systems toward integrated, outcomes-focused, and socially responsive models of care. As the link between addiction, mental health, and social determinants becomes more evident, pharmacological interventions are being embedded into broader ecosystems of recovery-spanning housing, employment, peer support, and justice reform.

Pharmaceutical and biotech players are leveraging this momentum to explore adjacent therapeutic areas such as post-traumatic stress disorder, chronic pain without opioids, and neuroregeneration-expanding the innovation horizon beyond conventional addiction treatment. Collaborative funding models involving public health agencies, insurers, and tech-enabled care providers are enabling a data-rich, patient-centered approach to treatment personalization.

With societal attitudes shifting from criminalization to compassion and science-driven care, could addiction therapeutics become the cornerstone of a global transformation in how we treat, perceive, and ultimately prevent substance-related and behavioral health disorders?

SCOPE OF STUDY:

The report analyzes the Addiction Therapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics, Drug Addiction Therapeutics); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Alkermes plc
  • Alkaloid AD Skopje
  • Biovail Corporation
  • Camurus AB
  • Durect Corporation
  • Indivior PLC
  • Jazz Pharmaceuticals plc
  • Lundbeck A/S
  • Mallinckrodt Pharmaceuticals
  • MediciNova, Inc.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Retrophin, Inc.
  • Shionogi & Co., Ltd.
  • Sunovion Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Titan Pharmaceuticals, Inc.
  • Zogenix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Addiction Therapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Substance Abuse and Mental Health Disorders Throws the Spotlight on Addiction Therapeutics
    • Growth in Public Health and Rehabilitation Spending Spurs Demand for Effective Treatment Options
    • Development of Opioid, Nicotine, and Alcohol Dependence Therapies Expands Drug Pipeline Activity
    • Integration With Behavioral Therapy Enhances Holistic Addiction Management Outcomes
    • Growth in Telemedicine and Digital Monitoring Tools Supports Continuity of Care
    • Use in Correctional Health Programs and Workplace Wellness Initiatives Broadens Treatment Access
    • Expansion of Harm Reduction Programs Promotes Preventive and Early Intervention Approaches
    • Government Incentives and Orphan Drug Designations Support Commercial Viability of Niche Treatments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Addiction Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Alcohol Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Alcohol Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Alcohol Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Tobacco Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Tobacco Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Tobacco Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Drug Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Drug Addiction Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Drug Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • JAPAN
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • CHINA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • EUROPE
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Addiction Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • FRANCE
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • GERMANY
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Addiction Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • INDIA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Addiction Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Addiction Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Addiction Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030
  • AFRICA
    • Addiction Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Addiction Therapeutics by Type - Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Addiction Therapeutics by Type - Percentage Breakdown of Value Sales for Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics and Drug Addiction Therapeutics for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Addiction Therapeutics by Distribution Channel - Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Addiction Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy and Other Distribution Channels for the Years 2014, 2025 & 2030

IV. COMPETITION